Dundee Corporation Acquires Further Interest in Diagnos Inc.

Dundee Corporation Acquires Further Interest in Diagnos Inc. 
TORONTO, ONTARIO -- (Marketwire) -- 02/08/13 -- In accordance with
regulatory requirements, Dundee Corporation (TSX:DC.A) ("Dundee")
announces that it has acquired 6,000,000 units ("Units") of Diagnos
Inc. ("Diagnos") in a private placement at a price of $0.10 per Unit.
Each Unit consists of one common share in the capital of Diagnos and
one common share purchase warrant ("Warrant"). Each Warrant entitles
the holder to purchase one common share at the price of $0.15 for a
period of 18 months. 
Dundee now owns a position in Diagnos representing an approximate
14.98% interest or 22.96% assuming the exercise of all Warrants. 
The position in Diagnos was acquired for investment purposes and may
be increased or decreased in the future as considered appropriate in
light of investment criteria, market conditions and other factors and
in accordance with the provisions of applicable securities
legislation.
Contacts:
Dundee Corporation
Ned Goodman
President and Chief Executive Officer
(416) 365-5665 
Dundee Corporation
Lucie Presot
Vice President and Chief Financial Officer
(416) 365-5157
 
 
Press spacebar to pause and continue. Press esc to stop.